Christophe Toukam Tchakoute1, Kristin Lynn Sainani1, Sophia Osawe2, Pam Datong2, Agano Kiravu3, Kenneth L Rosenthal4, Clive M Gray3, D William Cameron5, Alash'le Abimiku2,6, Heather B Jaspan3,7. 1. Division of Epidemiology, Stanford School of Medicine, Stanford, California, USA. 2. Plateau State Human Virology Research Center, Jos, Nigeria. 3. Division of Immunology, Institute of Infections Disease and Molecular Medicine, University of Cape Town, South Africa. 4. McMaster University. 5. Division of Infectious Diseases, Department of Medicine, University of Ottawa at The Ottawa Hospital/Research Institute, Ontario, Canada. 6. Institute of Human Virology, University of Maryland, Maryland. 7. Seattle Children's Research Institute and Department of Pediatrics and Global Health, University of Washington, Seattle, Washington, USA.
Abstract
OBJECTIVE: The effects of in-utero HIV-exposure on infectious morbidity and mortality in settings with universal maternal treatment and high breastfeeding rates are unclear. Further, the benefits of exclusive feeding options have not been assessed in the Option B+ era. We investigated these in two African settings with high breastfeeding uptake and good HIV treatment infrastructure during the first year of life. METHODS: Cox regression with time-changing variables in a birth cohort of 749 HIV-exposed uninfected and HIV-unexposed uninfected infants from Cape Town, South Africa and Jos, Nigeria. RESULTS: There was no difference in infectious morbidity incidence between HIV-exposed uninfected and HIV-unexposed uninfected infants (hazard ratio 1.01; 95% CI 0.78-1.32) after adjusting for confounding variables. Formula-fed infants had significantly higher infectious morbidity incidence when compared with exclusively breastfed infants (hazard ratio 1.64; 95% CI 1.03-2.63) and mixed-breastfed infants (hazard ratio 1.42; 95% CI 1.00-2.02) after adjusting for potential confounding variables. There was no significant difference in mortality among HIV-exposed infants and HIV-unexposed infants during the first year of life in this cohort (2.04 versus 0.94%, P = 0.38). Notably, exclusive breastfeeding for only 4 months had protective effects on morbidity up to 1 year. CONCLUSION: In settings with universal antiretroviral coverage and high breastfeeding rates, breastfeeding mitigates the effects of in-utero HIV exposure among infants during the first year of life. These findings support previous recommendations for exclusive breastfeeding among HIV-infected women and highlight the role that breastfeeding plays on the health of infants in settings where exclusive breastfeeding is not always feasible or where replacement feeding is recommended.
OBJECTIVE: The effects of in-utero HIV-exposure on infectious morbidity and mortality in settings with universal maternal treatment and high breastfeeding rates are unclear. Further, the benefits of exclusive feeding options have not been assessed in the Option B+ era. We investigated these in two African settings with high breastfeeding uptake and good HIV treatment infrastructure during the first year of life. METHODS:Cox regression with time-changing variables in a birth cohort of 749 HIV-exposed uninfected and HIV-unexposed uninfected infants from Cape Town, South Africa and Jos, Nigeria. RESULTS: There was no difference in infectious morbidity incidence between HIV-exposed uninfected and HIV-unexposed uninfected infants (hazard ratio 1.01; 95% CI 0.78-1.32) after adjusting for confounding variables. Formula-fed infants had significantly higher infectious morbidity incidence when compared with exclusively breastfed infants (hazard ratio 1.64; 95% CI 1.03-2.63) and mixed-breastfed infants (hazard ratio 1.42; 95% CI 1.00-2.02) after adjusting for potential confounding variables. There was no significant difference in mortality among HIV-exposed infants and HIV-unexposed infants during the first year of life in this cohort (2.04 versus 0.94%, P = 0.38). Notably, exclusive breastfeeding for only 4 months had protective effects on morbidity up to 1 year. CONCLUSION: In settings with universal antiretroviral coverage and high breastfeeding rates, breastfeeding mitigates the effects of in-utero HIV exposure among infants during the first year of life. These findings support previous recommendations for exclusive breastfeeding among HIV-infectedwomen and highlight the role that breastfeeding plays on the health of infants in settings where exclusive breastfeeding is not always feasible or where replacement feeding is recommended.
Authors: Sonwabile Dzanibe; Katie Lennard; Agano Kiravu; Melanie S S Seabrook; Berenice Alinde; Susan P Holmes; Catherine A Blish; Heather B Jaspan; Clive M Gray Journal: J Immunol Date: 2021-11-24 Impact factor: 5.422
Authors: Bryan P Brown; Denis Chopera; Enock Havyarimana; Jerome Wendoh; Shameem Jaumdally; Donald D Nyangahu; Clive M Gray; Darren P Martin; Arvind Varsani; Heather B Jaspan Journal: Virus Res Date: 2020-11-01 Impact factor: 3.303
Authors: Christina Balle; Blair Armistead; Agano Kiravu; Xiaochang Song; Anna-Ursula Happel; Angela A Hoffmann; Sami B Kanaan; J Lee Nelson; Clive M Gray; Heather B Jaspan; Whitney E Harrington Journal: J Clin Invest Date: 2022-07-01 Impact factor: 19.456
Authors: Ivan Mutawulira; Jane Nakachwa; Laymond Muharabu; Abel Wilson Walekhwa; Vincent Kayina Journal: Epidemiol Infect Date: 2022-06-20 Impact factor: 4.434